Fig. 26From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseBenzylpiperidinylamino derivative C18 and (2-fluorophenyl)piperazine derivative C19Back to article page